This is a report of hemolytic anemia and respiratory failure due to Mycoplasma pneumoniae pneumonia. His chest CT scans showed bilateral diffuse thickened bronchovascular bundles and emphysematouschanges. The pulmonary function test supported the diagnosis of chronic obstructive pulmonary disease (COPD). He was diagnosed as coldagglunitin-associated hemolytic anemia and M. pneumoniae pneumonia in inapparent COPD.Corticosteroid administration was remarkablly effective for hemolytic anemia and beneficial for acute exacerbation of COPD. (Internal Medicine 41: 229-232, 2002) 
Introduction
Extrapulmonary manifestations such as hemolytic anemia, myocarditis, pericarditis, meningoencephalitis, and a variety of skin lesions, are not commonin Mycoplasmapneumoniae infection. Involvement of the extrapulmonary manifestations may explain the pathogenesis of immune-complex disease ( 1), produced by circulating complexes of antibody and complement bound to mycoplasma. Once diagnosed as extrapulmonary manifestations of Mycoplasmapneumoniae infection, corticosteroid therapy seems reasonable in addition to specific antimicrobial therapy. Furthermore, corticosteroid should be administered to patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) (2) . Herein is an unique case of simultaneous occurrence of hemolytic anemiaand respiratory failure due to M. pneumoniaepneumoniain inapparent COPD.
Case Report
A 49-year-old manwas transferred to our ICU, because of respiratory failure and jaundice on December 15, 2000. He had no significant pleuropulmonary history other than smoking (2 packs of cigarettes daily for 29 years). He had medication for hypertension and diabetes mellitus. He was well until ten days previously, when flu-like symptomsdeveloped. The symptoms continued until two days before admission. He was admitted to a hospital because of dyspnea with wheeze and nonproductive cough. A physician diagnosed bacterial pneumonia and treated him with flomoxef. Onthe day of admission to our ICU, he began to have jaundice and dark urine. On admission, he appeared dyspneic and mildly jaundiced. His heart rate was 115 beats/min, respiratory rate was 32 breaths/min, blood presure was 175/100 mmHg, and body temperature was 37.6°C. Auscultation of the lungs revealed wheezes. There were no abnormal findings of his heart, abdomen, extremities, or nervous system. Laboratory examinations on admission showed the following results; hemoglobin (Hb) 8.5 g/dl, hematocrit 23.8%, red blood cell (RBC) 259xlO4/|il, white blood cell 38,200/|il, neutrophils 90.5%, lymphocytes 4.0%, monocytes 4.0%, eosinophils 0.5%, and atypical lymphocytes 1.0%, platelet count 58.8xlO4/|ul, C-reactive protein 27.6 mg/dl, urea nitrogen 21 mg/dl, glucose 278 mg/dl, total bilirubin 5. 1 mg/dl, direct conjugated bilirubin 1.0 mg/dl, haptoglobin 8.0 mg/dl, lactate dehydrogenase 1 ,889 IU//, creatine kinase 807 IU//, aspartate aminotransferase 72 IU//, alanine aminotransferase 26 IU//, prothrombin time 1 3.3 seconds (control 12.3 seconds), partial thromboplastin time 36.7 seconds (control 3 1.7 seconds). The urine was red and gave a markedly positive test for occult blood, glucose and protein. The arterial blood gas (ABG) analysis under 9 //min oxygen revealed; PaO2 41.6 mmHg, PaCO2 47.4 mmHg, pH 7.37. His chest radiograph showed bilateral diffuse infiltrates involving bilateral lower lobes (Fig. 1) . The chest CT scans revealed diffuse thickened bronchovascular bundles, emphysematouschanges and mucoid impactions ( Fig. 2A and 2B) . The tuberculin skin test He was intubated and mechanically ventilated. The ventilator setting was pressure controlled, fraction of inhaled oxygen 0.7, and positive endexpiratory pressure 3 cm H2O. The ABG analysis revealed; PaO2 133.8 mmHg, PaCO2 54.8 mmHg, pH 7.35, and Hb 6.5 g/dl. The decrease of Hb was due to intravascular hemolysis and hematuria. A test for cold agglutinins was positive in a titer of 1:1,024, and a Coombstest was positive only for complement. He was treated with 4,000 units of haptoglobin, 2 units of warmed packed RBCs, 500 mg of erythromycin (EM), and 500 mgof meropenem. His extremities were kept warm. At 21 hours after admission, the steroid pulse therapy (methylprednisolone 1 g daily for 3 days) was added because the former treatments did not improve anemia and hematuria. The color of urine turned amber2 hours later and normal yellow 15 hours later, after the intravenous steroid. However,he needed 4 more units of RBCtransfusion to maintain Hb at more than 6.0 g/dl for 2 days. Finally, he was diagnosed as 1) Mycoplasma pneumoniae pneumoniawith cold-agglunitin-associated hemolytic anemia, when his antimycoplasma antibody titer by complement fixation was high as >1:1,024 on the 4th and on the 12th hospital days, 2) COPD, 3) diabetes mellitus. He had been treated with EMor clarithromycin for 2 weeks, prednisolone tapering therapy following the steroid pulse therapy (Fig. 3) , inhalation of oxitropium bromide, and intravenous insulin. He was extubated on the 8th hospital day. His pulmonary function test on the 1 1th hospital day revealed; forced vital capacity 3,530 ml, forced expiratory volume in 1 second (FEV, 0) 2,420 ml, FEV, 0% 68.5%, %FEV, 0 69.7%, peak flow rate 6.63 //second. (Fig. 4) . He was transferred to the previous hospital on the 14th hospital day.
Discussion
Mycoplasma pneumoniae infection has been well recognized as one of the causes for acute exacerbation of asthma. Likewise, in patients with COPD,M. pneumoniae infection might be associated with acute exacerbation of COPD (3) . In the present patient, COPDhad not been detected until the chest CTshowed bilateral emphysematous changes. However, he had been a current smoker and having symptomsof dyspnea and wheezes. Furthermore, his pulmonary function test revealed obstructive pattern and no effect of beta2-agonists on FEV, 0
Mycoplasma-induced Hemolysis & Hypoxemia Hemolytic anemia due to M. pneumoniae infection is less commonthan acute respiratory failure due to this organism. This hemolytic anemia is related to cold agglutination. Coldagglutinin-associated hemolytic anemia is seen in three clinical situations; 1) during the course of certain infections such as mycoplasma pneumonia, 2) in association with lymphoproliferative disease such as lymphoma, and 3) in idiopathic coldagglutinin disease (4). M. pneumoniae infection stimulates the production of autoantibodies not only to lung but also to brain, smooth muscle and RBCs. The interaction of I antigen on the surface of RBCswith M. pneumoniaeis speculated (5). However, the pathogenesis of autoimmunephenomenais not clear.
Interestingly, remarkable leukocytosis was seen in this case. A leukocyte count less than 10,000/|il is commonin M. pneumoniae pneumonia. However, previous reports on M. pneumoniae pneumonia with hemolytic anemia showed leu-kocytosis (5, 6). The difference is unknown but leukocytosis in M. pneumoniaepneumonia might be a clue to suspect the existence of hemolytic anemia. The therapy for hemolytic anemia associated with M. pneumoniae pneumonia depends on the severity of anemia. In addition to treating the patient with the specific antimicrobials, keeping their extremities warmis important and the packed RBCsshould be warmedbefore transfusion. To administer steroids in such a patient seems reasonable. The response appears to be quick and dramatic (6, 7) , as seen in the present case. However, no formal treatment studies on hemolytic anemia have been carried out. In conculusion, the simultaneous occurrence of hemolytic anemia and respiratory failure due to M. pneumoniae pneumonia is a unique case. Severeanemiaand hematuria respondwell to high-dose corticosteroid therapy. The steroid tapering therapy following the pulse therapy may be beneficial for respiratory failure in inapparent COPD.
